Welcome
Support Centre
01 September 2014 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes
statistics

[ ...Back to search results ] [ Print-friendly version ]
IMproving the PRevention Of Vascular Events after stroke or transient ischemic attack
ISRCTN ISRCTN63816609
DOI 10.1186/ISRCTN63816609
ClinicalTrials.gov identifier
EudraCT number
Public title IMproving the PRevention Of Vascular Events after stroke or transient ischemic attack
Scientific title IMproving the PRevention Of Vascular Events after stroke or transient ischemic attack: a randomised controlled pilot trial of nurse independent prescriber-led care pathway-based risk factor management
Acronym IMPROVE
Serial number at source 9026
Study hypothesis Our pilot trial will be trying to improve the treatment of risk factors like blood pressure after a mini-stroke. The trial will compare ‘usual care’ (having your risk factors treated the way they are at the moment, usually by visits to the GP with an approach that puts treatment in the hands of a new type of nurse, who will prescribe treatment according to a specially-designed plan called a ‘care pathway’. We are hoping this will mean that the person’s risk factors will be better controlled, and their risk of another stroke is reduced. We will check on people’s blood pressure using an automatic arm cuff during normal activities – an ‘ambulatory monitor’, which gives a more reliable result than measurements taken in the clinic. After six months and again after a year we will compare the effects of treatment between ‘usual care’ and the new approach, to see if one is better than the other.

Any treatment is only effective if people can stick with it, and we know that a lot of people on prescribed drugs give up taking them for various reasons. In this trial people will get the chance to tell the researchers the good and bad things about taking part, and whether the new type of nurse-led care pathway worked for them. This is important so that we can understand the things that would help people to stay on treatment. If our pilot is successful, we will go ahead with a larger study.

More details can be found at http://public.ukcrn.org.uk/Search/StudyDetail.aspx?StudyID=9026
Lay summary Not provided at time of registration
Ethics approval ref: 10/H0106/46
Study design Randomised interventional prevention process of care trial
Countries of recruitment United Kingdom
Disease/condition/study domain Stroke
Participants - inclusion criteria 1. Clinical diagnosis of transient ischemic attack (TIA) or stroke within one month
2. Patient is living at home at time of recruitment
3. Ag e> 18 years
4. systolic blood pressure (SBP) > 140 mmHg measured at time of diagnosis of stroke or TIA
5. Registered with ageneral practitioner (GP) in one of the two pilot clusters (Exete and East Devon)
6. Ability to attend for follow-up visits
7. Given iInformed consent
8. Male or female participants
Participants - exclusion criteria 1. Severe dementia or aphasia
2. Significant co-morbidity likely to jeopardise ability to complete the trial e.g. malignancy, severe heart failure
3. Current participation in other trials
Anticipated start date 04/01/2011
Anticipated end date 09/09/2011
Status of trial Completed
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants Planned Sample Size: 30
Interventions Secondary Prevention algorithm, Nurse Independent Prescriber-led, care pathway-based secondary vascular risk factor management.
Primary outcome measure(s) Ambulatory 12-hour daytime systolic blood pressure measured at 6 months
Secondary outcome measure(s) No secondary outcome measures
Sources of funding NIHR Research for Patient Benefit Programme (UK)
Trial website
Publications
Contact name Mrs  Nicola  Wedge
  Address Royal Devon & Exeter Hospital
Barrack Road
  City/town Exeter
  Zip/Postcode EX2 5DW
  Country United Kingdom
  Email nicola.wedge@rdeft.nhs.uk
Sponsor Royal Devon and Exeter Foundation Trust (UK)
  Address Royal Devon & Exeter Hospital
Barrack Road
  City/town Exeter
  Zip/Postcode EX2 5DW
  Country United Kingdom
  Tel +44 (0)1392 411611
  Email
  Sponsor website: http://www.rdehospital.nhs.uk/
Date applied 17/05/2012
Last edited 17/05/2012
Date ISRCTN assigned 17/05/2012
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2014 ISRCTN unless otherwise stated.